Oxybutynin Chloride
Product Images NDC 50090-4728

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 50090-4728). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500904728)

FDA Label Image

1 (Oxybutynin Chloride Extended Release Tablets Usp 1)

FDA Label Image

Figure 1 (Oxybutynin Chloride Extended Release Tablets Usp 2)

Figure 1 (Oxybutynin Chloride Extended Release Tablets Usp 2)
This text provides information on the mean plasma concentration of R-oxybutynin measured in ng/mL. It also includes two treatment protocols involving oxybutynin chloride ER tablets and oxybutynin 5mg taken three times a day. The numbers '16', '20', and '22' likely refer to data points or measurements.*
FDA Label Image

Figure 2 (Oxybutynin Chloride Extended Release Tablets Usp 3)

FDA Label Image

1 (Oxybutynin Chloride Extended Release Tablets Usp 4)

FDA Label Image

1 (Oxybutynin Chloride Extended Release Tablets Usp 5)

FDA Label Image

1 (Oxybutynin Chloride Extended Release Tablets Usp 6)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.